PBI-1308

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NamePBI-1308
Drug Alias NamePBI-1308
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionImmunoglobulin G modulators
TargetsImmunoglobulin G
Therapy Area/IndicationsAutoimmune DiseasesPsoriasisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMexico
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLiminal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesPsoriasisDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A